106 related articles for article (PubMed ID: 29704897)
1. Occurrence of anembryonic pregnancy with use of levonorgestrel subdermal implant (JADELLE®): a case report.
Moutchia-Suh J; Mouemba DM; Ngwasiri CA
J Med Case Rep; 2018 Apr; 12(1):111. PubMed ID: 29704897
[TBL] [Abstract][Full Text] [Related]
2. Predictors of Discontinuation of Subdermal Levonorgestrel Implants (Jadelle) at the Lagos University Teaching Hospital, Lagos, Nigeria: An Analytic Cohort Study.
Ohazurike E; Olamijulo JA; Ibisomi L; Olorunfemi G; Oluwole AA
Afr J Reprod Health; 2020 Jun; 24(2):48-63. PubMed ID: 34077091
[TBL] [Abstract][Full Text] [Related]
3. New Zealand women's experience during their first year of Jadelle® contraceptive implant.
Roke C; Roberts H; Whitehead A
J Prim Health Care; 2016 Mar; 8(1):13-9. PubMed ID: 27477370
[TBL] [Abstract][Full Text] [Related]
4. Jadelle subdermal implants. Preliminary experience in a teaching hospital in the Niger Delta Region of Nigeria.
Enyindah CE; Kasso T
Niger J Med; 2011; 20(2):270-4. PubMed ID: 21970242
[TBL] [Abstract][Full Text] [Related]
5. Levonorgestrel subdermal implants. Contraception on trial.
Frank ML; DiMaria C
Drug Saf; 1997 Dec; 17(6):360-8. PubMed ID: 9429835
[TBL] [Abstract][Full Text] [Related]
6. Enlarged ovarian follicles in users of a levonorgestrel-releasing intrauterine system and contraceptive implant.
Bahamondes L; Hidalgo M; Petta CA; Diaz J; Espejo-Arce X; Monteiro-Dantas C
J Reprod Med; 2003 Aug; 48(8):637-40. PubMed ID: 12971147
[TBL] [Abstract][Full Text] [Related]
7. Effects of Jadelle used in Thai women aged between 20 and 45 years in King Chulalongkorn Memorial Hospital.
Laphikanont W; Taneepanichskul S
J Med Assoc Thai; 2006 Jun; 89(6):761-6. PubMed ID: 16850674
[TBL] [Abstract][Full Text] [Related]
8. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
Laurikka-Routti M; Haukkamaa M
Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
[TBL] [Abstract][Full Text] [Related]
9. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
[TBL] [Abstract][Full Text] [Related]
10. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
McNicholas C; Swor E; Wan L; Peipert JF
Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
[TBL] [Abstract][Full Text] [Related]
11. Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants.
Hidalgo MM; Lisondo C; Juliato CT; Espejo-Arce X; Monteiro I; Bahamondes L
Contraception; 2006 May; 73(5):532-6. PubMed ID: 16627041
[TBL] [Abstract][Full Text] [Related]
12. Ulnar neuropathy associated with subdermal contraceptive implant.
Marin R; McMillian D
South Med J; 1998 Sep; 91(9):875-8. PubMed ID: 9743065
[TBL] [Abstract][Full Text] [Related]
13. A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Apter D; Briggs P; Tuppurainen M; Grunert J; Lukkari-Lax E; Rybowski S; Gemzell-Danielsson K
Fertil Steril; 2016 Jul; 106(1):151-157.e5. PubMed ID: 27016644
[TBL] [Abstract][Full Text] [Related]
14. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
15. [Application of levonorgestrel-releasing intrauterine system in early pregnancy: a case report].
Gardyszewska A; Czajkowski K
Ginekol Pol; 2012 Dec; 83(12):950-2. PubMed ID: 23488301
[TBL] [Abstract][Full Text] [Related]
16. In vivo release of levonorgestrel from Sino-implant (II) — an innovative comparison of explant data.
Callahan RL; Taylor D; Jenkins DW; Owen DH; Cheng L; Cancel AM; Dorflinger LJ; Steiner MJ
Contraception; 2015 Oct; 92(4):350-5. PubMed ID: 26142619
[TBL] [Abstract][Full Text] [Related]
17. Norplant-2 subdermal contraceptive system: experience in Taiwan.
Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
[TBL] [Abstract][Full Text] [Related]
18. Comments on two subdermal implant articles.
Mansour D
J Fam Plann Reprod Health Care; 2011 Apr; 37(2):119-20; author reply 120-1. PubMed ID: 21454275
[No Abstract] [Full Text] [Related]
19. Norplant neuropathy: peripheral neurologic symptoms associated with subdermal contraceptive implants.
Hueston WJ; Locke KT
J Fam Pract; 1995 Feb; 40(2):184-6. PubMed ID: 7852942
[TBL] [Abstract][Full Text] [Related]
20. Subdermal levonorgestrel implants. Three years' experience in Cairo, Egypt.
Rizk DE
J Reprod Med; 1995 Sep; 40(9):638-44. PubMed ID: 8576880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
